drug costs

Top challenges in cancer careCancer drug costs remain the most critical challenge in care, among other things.
AMA drives push for drug pricing transparency with grassroots campaignThe AMA has emphasized a need for drug pricing transparency by encouraging patients to share their stories on its TruthinRx.org website.
Four ways Medicare Part D has affected costs for diabetic patientsUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.
How state-mandated formularies impact costsResearch by Express Scripts presented at the AMCP examines costs among Medicaid members in the Florida plan to members in a similar Medicaid plan without a state-mandated formulary.
Tips to help patients lower costsThere are some things that dermatologists can do now to help patients lower their drug costs.
Can we lower drug costs?
Can we lower drug costs?Experts discuss the forces contributing to costs that are rising faster in the United States than in other countries, as well as what dermatologists can do now to help patients get access to more affordable medications.
Will Trump follow through with an ACA repeal?In this commentary, Gerard J. Wedig of Simon Business School discusses the many possible implications of a Trump presidency.
Four things health execs should know about the oncology pipeline
Four things health execs should know about the oncology pipelineHere’s how you can recognize changes in the oncology pipeline and maximize value related to cancer care.
Copay assistance programs: Managed care pros and consDo copay assistance program offer a long-term solution for patients? Experts weigh in.
What executives must know to combat rising drug spendIn today’s healthcare landscape, few things better define the role of a managed healthcare executive than managing the industry’s constant changes.